XIV. The rationale for combining targeted and biological anti-lymphoma drugs Journal Article
| Author: | Younes, A. |
| Article Title: | XIV. The rationale for combining targeted and biological anti-lymphoma drugs |
| Keywords: | histone deacetylase inhibitor; patient selection; antineoplastic agent; mantle cell lymphoma; mitogen activated protein kinase inhibitor; prediction; nonhodgkin lymphoma; lymphoma; large cell lymphoma; akt; mammalian target of rapamycin inhibitor; follicular lymphoma; burkitt lymphoma; pi3k; phase 2 clinical trial (topic); janus kinase 2 inhibitor; anaplastic lymphoma; crizotinib; jak; stat; blk |
| Journal Title: | Hematological Oncology |
| Volume: | 31 |
| Issue: | Suppl. 1 |
| ISSN: | 0278-0232 |
| Publisher: | Wiley Blackwell |
| Date Published: | 2013-06-01 |
| Start Page: | 81 |
| End Page: | 83 |
| Language: | English |
| DOI: | 10.1002/hon.2072 |
| PROVIDER: | scopus |
| PUBMED: | 23775656 |
| DOI/URL: | |
| Notes: | --- - "Export Date: 1 August 2013" - "CODEN: HAOND" - "Source: Scopus" |
